The Cicerone group has been awarded a 3-year grant by the National Cancer Institute to use broadband coherent anti-Stokes Raman scattering to develop a label-free microscopy that maps metabolic state of tissues on a cell-by-cell basis. The metabolic information obtained will be used to help physicians diagnose and stratify cancer in solid tumors such as prostate and breast cancer. The grant number is 1 R21 CA240214-01A1.